Publication:
Efficacy and Treatment Persistence of First-Line Natalizumab vs. Interferon Beta or Glatiramer Acetate in Relapsing MS

Simple item page
dc.contributor.authorButzkueven, H.
dc.contributor.authorSpelman, T.
dc.contributor.authorKalincik, T.
dc.contributor.authorJokubaitis, V.
dc.contributor.authorZhang, A.
dc.contributor.authorPellegrini, F.
dc.contributor.authorLa Spitaleri, D.
dc.contributor.authorIDBelachew, Shibeshih/0000-0003-3976-1950
dc.contributor.authorIDHorakova, Dana/0000-0003-1915-0036
dc.contributor.authorIDLugaresi, Alessandra/0000-0003-2902-5589
dc.contributor.authorIDHavrdova, Eva Kubala/0000-0002-9543-4359
dc.date.accessioned2020-06-21T13:34:14Z
dc.date.available2020-06-21T13:34:14Z
dc.date.issued2016
dc.departmentOMÜen_US
dc.department-temp[Butzkueven, H. -- Spelman, T. -- Kalincik, T. -- Jokubaitis, V.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne, Vic 3010, Australia -- [Butzkueven, H. -- Spelman, T. -- Kalincik, T.en_US
dc.description8th Congress of the Pan-Asian-Committee-for-Research-and-Treatment-of-Multiple-Sclerosis (PACTRIMS) -- NOV 19-21, 2015 -- Seoul, SOUTH KOREAen_US
dc.description.abstract…en_US
dc.description.sponsorshipPan Asian Comm Treatment & Res Multiple Sclerosisen_US
dc.identifier.endpage419en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.issue3en_US
dc.identifier.startpage418en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/13472
dc.identifier.volume22en_US
dc.identifier.wosWOS:000372242400086
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEfficacy and Treatment Persistence of First-Line Natalizumab vs. Interferon Beta or Glatiramer Acetate in Relapsing MSen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu